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T he vascular system, which was initially considered a simple conduit for the passage of blood and its nutrients to organs, is now considered a complex molecular network that connects a heterogeneous group of cells that are practically involved in all aspects of health and disease. The rapid expansion of the field of vascular biology in recent years has provided novel insights not only into the molecular mechanisms of various cardiovascular diseases, such as atherosclerosis, thrombosis, hypertension and aneurysms, but as into the pathogenesis of non-cardiovascular diseases, such as tumor angiogenesis, inflammation, and regulation of whole body and organ metabolism.
The complexity of the vascular system extends beyond the heterogeneity of its cellular composition, which is comprised of the endothelial cells, smooth muscle cells, fibroblasts and pericytes, among the others. It also encompasses functional heterogeneity within each cell type in the vessel wall. Endothelial cells, which form the inner lining of the vascular system, display considerable functional and structural heterogeneity, which might in part reflect the adaptive capacity of the different vascular territories to internal and environmental demands. 1 The breadth of functional diversity of the endothelium is exemplified with endothelial hemogenesis, whereby the endothelium serves as a source of blood cells, at least during embryonic development. 2 Likewise, vascular smooth muscle cells exhibit a mosaic pattern of functions and distributions, reflective of the multiplicity of their embryonic origins. 3 While the smooth muscle cells in the proximal ascending aorta originate from neural crest cells, those in the descending aorta originate from mesodermal cells and those in coronaries from pro-epicardium. 3 The multiplicity of developmental origin of vascular smooth muscle cells might be responsible for segmental variability in susceptibility to vascular diseases, such as atherosclerosis and aortic aneurysm. Moreover, interactions among cellular constituents of the vessel wall regulate angiogenesis, vasculogenesis, vascular remodeling and functions. Understanding of the molecular basis of functional and phenotypic heterogeneity of cellular composition of the vessel wall and the mechanisms that govern their complex homeostasis might afford opportunities to garner therapeutic gains while lessening fortuitous untoward effects of interventions.
The vasculature is an exceedingly active biological organ with functions ranging from maintaining intravascular volume and vascular tone to regulation of thrombosis and angiogenesis. A complicated network of regulatory and signaling pathways that exhibit immense plasticity in response to internal as well as external stimuli govern functions of each cellular constituent of the vascular system as well as the interactions among them. The discovery of endothelial -derived relaxation factor (EDRF), which is now known as nitric oxide (NO), by Furchgott (1998 Nobel Laureate) serves as an archetypical evidence of complex biological activity of the vasculature. 4 Molecular plasticity of vascular cells in producing panoply of autocrine and paracrine factors and hormones, such as angiotensin II, endothelins, prostacyclin, and vascular endothelial growth factor in response to various stimuli has been extensively demonstrated. Likewise, the contributions of these trophic and mitotic factors to local and systemic biological and pathological processes are well recognized.
Moreover, the signaling cascades that regulate the responses to external and internal stimuli including response to autonomic outflow from the hypothalamic region and the neurotransmitters are well characterized. Furthermore, vascular microRNA and non-coding RNAs have emerged as major regulators of vessel wall homeostasis and pathologies. [5] [6] [7] [8] [9] [10] [11] [12] [13] These molecular networks are currently being investigated as specific targets for interventions to prevent and assuage vascular diseases.
Since identification of the first specific angiogenic molecule by Folkman and colleagues in 1971, a large number of proangiogenic factors have been identified and characterized. 14 However, in spite of plausibility of the approach in provoking new vessel formation and alleviating tissue ischemia, direct delivery of angiogenic factors via gene and cell therapy or protein delivery to the myocardium or peripheral tissues has thus far been unsuccessful clinically. 15, 16 Identification of resident and circulating vascular progenitor cells has shifted the emphasis from direct delivery of the angiogenic factors toward harnessing the therapeutic potentials of vascular progenitor cells in angiogenesis. Induced pluripotent stem cells (iPSCs), generated upon expression of a defined set of transcription factors in differentiated cells, 17 as well as bone marrow derived mesenchymal stem cells have been successfully applied in experimental models of angiogenesis. [18] [19] [20] [21] Nevertheless, the field is in the early stages of its evolution. New approaches are being developed and applied to enhance angiogenesis either through delivery of vascular stem cells alone or in conjunction with angiogenic factors. Understanding the fundamental mechanisms that regulate vascular stem cell proliferation, differentiation, maturation and organogenesis is likely to dominant the field of vascular biology in the coming years.
Circulation Research is leading journal for disseminating clinical, translational and basic science discoveries in vascular diseases. The Editors of Circulation Research are committed to publishing the cutting edge novel scientific discoveries in molecular biology of the vascular system.
The following represent a selection of recently published Circulation Research articles on vascular biology & disease, presented in their reverse order of publication. Articles highlighted in yellow represent the top 5 most read original research articles selected based on the number of Full Text/ PDF downloads, adjusted to compensate for differences in the length of time since online publication. differentiate into various cell types, including cells of coronary blood vessels and cardiac interstitial cells. Epicardial cells and epicardium-derived cells signal to the adjacent cardiac muscle in a paracrine fashion, promoting its proliferation and expansion. Recently, high expectations have been raised about the epicardium as a candidate source of cells for the repair of the damaged heart. Because of its developmental importance and therapeutic potential, current research on this topic focuses on the complex signals that control epicardial biology. This review describes the signaling pathways involved in the different stages of epicardial development and discusses the potential of epicardial signals as targets for the development of therapies to repair the diseased heart.
AMPKα2 Deletion Exacerbates Neointima Formation by Upregulating Skp2 in Vascular Smooth Muscle Cells; Song et al 23

What Is Known?
• AMP-activated protein kinase (AMPK), a key energy gauge and redox sensor, inhibits cell proliferation in vascular smooth muscle cells (VSMC). • The eukaryotic cell cycle is regulated by a series of protein complexes composed of cyclins, catalytic cyclin-dependent kinases (CDKs), and their cyclin-dependent kinase inhibitors (CKIs), including p27Kip1. • The E3 ligase Skp2 is critical regulator of p27Kip1 degradation and neointima formation.
What New Information Does This Article Contribute?
• Inhibition/deletion of AMPKα2 in vitro and in vivo elevates p27Kip1 degradation in VSMC. • AMPKα2 deletion upregulates Skp2 transcription through the transcription factor NF-κB2. • Skp2 is necessary for AMPKα2 inhibition-augmented cell proliferation of VSMC. • AMPKα2 but not AMPKα1 deletion aggravates neointimal hyperplasia after vascular injury.
Conclusions
These findings indicate that deletion of AMPKα2 through p52-Skp2-mediated ubiquintination and degradation of p27Kip1 accentuates neointimal hyperplasia in response to wire injury.
Coupling of Fcγ Receptor I to Fcγ Receptor IIB by Src Kinase Mediates C-Reactive Protein Impairment of Endothelial Function; Sundgren et al 24
What is Known?
• Elevated levels of C-reactive protein (CRP) are associated with an increase in cardiovascular disease risk and endothelial dysfunction in humans. • CRP plays a causal role in hypertension and endothelial dysfunction in mice. • CRP antagonizes endothelial nitric oxide synthase (eNOS) through processes mediated by the IgG receptor Fcγ
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receptor IIB (FcγRIIB) and activation of the phosphatase SH2 domain-containing inositol 5′-phosphatase 1 (SHIP-1).
What New Information Does This Article Contribute?
• Inhibition of eNOS by CRP is mediated by the coupling of the activating Fcγ receptor I (FcγRI) to FcγRIIB by Src kinase that results in the activation of SHIP-1. • Both FcγRI and FcRIIB are required for CRP to blunt endothelial repair in vivo. • Similar processes mediate eNOS antagonism by aggregated IgG that mimics immune complexes.
Conclusions
CRP antagonism of eNOS is mediated by the coupling of FcγRI to FcγRIIB by Src kinase and resulting activation of SH2 domain-containing inositol 5′-phosphatase 1, and consistent with this mechanism, both FcγRI and FcγRIIB are required for CRP to blunt endothelial repair in vivo. Similar mechanisms underlie eNOS antagonism by immune complex. FcγRI and FcγRIIB may be novel therapeutic targets for preventing endothelial dysfunction in inflammatory or immune complex-mediated conditions.
MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation; Boon et al 25
What Is Known?
• Advanced age is a major risk factor for developing aneurysms. • MicroRNA-29 inhibits expression of several extracellular matrix proteins.
What New Information Does This Article Contribute?
• Advanced age induces microRNA-29 expression in the aorta and represses extracellular matrix expression. • MicroRNA-29 levels are increased in the aorta in animal models of aneurysm formation and patients with thoracic aneurysms. • Inhibition of microRNA-29 in vivo prevents aortic dilatation in mice.
Conclusion
In conclusion, miR-29-mediated downregulation of ECM proteins may sensitize the aorta to the formation of aneurysms in advanced age. Inhibition of miR-29 in vivo abrogates aortic dilation in mice, suggesting that miR-29 may represent a novel molecular target to augment matrix synthesis and maintain vascular wall structural integrity.
Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension; Tamosiuniene et al 26
What Is Known?
• Pulmonary arterial hypertension (PAH) is a potentially fatal condition associated with connective tissue diseases and viral infections.
• Perivascular inflammation is strongly associated with PAH, but whether lung immunity contributes to disease pathogenesis is controversial. • Regulatory T lymphocytes (Tregs) are important cells that control inflammation and prevent autoimmune injury.
What New Information Does This Article Contribute?
• Correcting immune deficiency prevents experimental PAH.
• The protective effect of IR was localized to Treg populations that prevented the early accumulation of macrophages and B cells, limited pulmonary endothelial apoptosis, and upregulated vascular bone morphogenetic protein receptor-II (BMPR2) expression.
Conclusions
PAH may arise when regulatory T-cell (Treg) activity fails to control endothelial injury. These studies suggest that regulatory T cells normally function to limit vascular injury and may protect against the development of PAH.
Netrin-4 Activates Endothelial Integrin α6β1; Larrieu-Lahargue et al 27
What Is Known?
• Netrins are laminin-like secreted proteins. They regulate angiogenesis, lymphangiogenesis, and tumor metastasis. • The identity of the endothelial receptors mediating the vascular effects of netrins remains unclear. • Noncanonical receptors, such as integrin α61, have been shown to modulate netrin functions in nonvascular context.
What New Information Does This Article Contribute?
• The α6β1, a laminin-1 receptor, expressed by human lymphatic endothelial cells, binds netrin-4 on a site different from its laminin-1 interaction domain. • This interaction regulates netrin-4-induced cell adhesion, migration, and focal adhesion contact, as α6 or β1 functionblocking antibodies or siRNA abrogate netrin-4-stimulated effects. • Both α6 and netrin-4 expression colocalize in vivo.
Conclusions
The α6β1 integrin is a netrin-4 receptor in lymphatic endothelium and consequently represents a potential target to inhibit netrin-4-induced metastatic dissemination.
findings indicating that elevated Ca and P have direct effects on vascular smooth muscle cells (VSMCs) that promote vascular calcification, including stimulation of osteogenic/ chondrogenic differentiation, vesicle release, apoptosis, loss of inhibitors, and extracellular matrix degradation. These studies suggest a major role for elevated P in promoting osteogenic/chondrogenic differentiation of VSMC, whereas elevated Ca has a predominant role in promoting VSMC apoptosis and vesicle release. Furthermore, the effects of elevated Ca and P are synergistic, providing a major stimulus for vascular calcification in CKD. Unraveling the complex regulatory pathways that mediate the effects of both Ca and P on VSMCs will ultimately provide novel targets and therapies to limit the destructive effects of vascular calcification in CKD patients.
Aortic Aneurysm Generation in Mice With Targeted Deletion of Integrin-Linked Kinase in Vascular Smooth Muscle Cells; Shen et al 29
What Is Known?
• Integrin-linked kinase (ILK) is a protein that associates with the cytoplasmic domain of β1 integrins and is thus well poised to transmit signals from within the cell to the extracellular milieu, and vice versa. • The in vivo role of ILK has been difficult to study because complete knockout confers early embryonic lethality, and thus investigators have turned to tissue specific deletion of this protein.
What New Information Does This Article Contribute?
• Deletion of ILK in vascular smooth muscle cells (SMC) in mice confers striking aneurysmal dilation of the aorta. • ILK deletion in primary aortic SMC triggers alterations in intracellular signaling, which ultimately manifest in the repression of the transcription and expression of genes that are required for the maintenance of the contractile SMC phenotype.
Conclusions
These data identify a molecular pathway linking ILK signaling to the contractile SMC gene program. Activation of this pathway is required for morphogenetic development of the aorta and ductus arteriosus during embryonic and postnatal survival.
Microparticles, Vascular Function, and Atherothrombosis [Review]; Rautou et al 30
Abstract
Membrane-shed submicron microparticles (MPs) are released after cell activation or apoptosis. High levels of MPs circulate in the blood of patients with atherothrombotic diseases, where they could serve as a useful biomarker of vascular injury and a potential predictor of cardiovascular mortality and major adverse cardiovascular events. Atherosclerotic lesions also accumulate large numbers of MPs of leukocyte, smooth muscle cell, endothelial, and erythrocyte origin. A large body of evidence supports the role of MPs at different steps of atherosclerosis development, progression, and complications. Circulating MPs impair the atheroprotective function of the vascular endothelium, at least partly, by decreased nitric oxide synthesis. Plaque MPs favor local inflammation by augmenting the expression of adhesion molecule, such as intercellular adhesion molecule -1 at the surface of endothelial cell, and monocyte recruitment within the lesion. In addition, plaque MPs stimulate angiogenesis, a key event in the transition from stable to unstable lesions. MPs also may promote local cell apoptosis, leading to the release and accumulation of new MPs, and thus creating a vicious circle. Furthermore, highly thrombogenic plaque MPs could increase thrombus formation at the time of rupture, together with circulating MPs released in this context by activated platelets and leukocytes. Finally, MPs also could participate in repairing the consequences of arterial occlusion and tissue ischemia by promoting postischemic neovascularization.
Genetics in Arterial Calcification: Pieces of a Puzzle and Cogs in a Wheel [Review]; Rutsch et al 31
Abstract
Artery calcification reflects an admixture of factors such as ectopic osteochondral differentiation with primary host pathological conditions. We review how genetic factors, as identified by human genome-wide association studies, and incomplete correlations with various mouse studies, including knockout and strain analyses, fit into "pieces of the puzzle" in intimal calcification in human atherosclerosis, and artery tunica media calcification in aging, diabetes mellitus, and chronic kidney disease. We also describe in sharp contrast how ENPP1, CD73, and ABCC6 serve as "cogs in a wheel" of arterial calcification. Specifically, each is a minor component in the function of a much larger network of factors that exert balanced effects to promote and suppress arterial calcification. For the network to normally suppress spontaneous arterial calcification, the "cogs" ENPP1, CD73, and ABCC6 must be present and in working order. Monogenic ENPP1, CD73, and ABCC6 deficiencies each drive a molecular pathophysiology of closely related but phenotypically different diseases (generalized arterial calcification of infancy (GACI), pseudoxanthoma elasticum (PXE) and arterial calcification caused by CD73 deficiency (ACDC)), in which premature onset arterial calcification is a prominent but not the sole feature.
Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung Disease; Noureddine et al 32
• Chronic obstructive pulmonary disease (COPD) is an agerelated disease that is among the most common causes of pulmonary hypertension (PH). • COPD is associated with telomere shortening, which causes cell senescence. • The role for telomere shortening as a pathogenic mechanism in COPD is unknown.
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• PH severity is related to telomere shortening in COPD, and remodeled pulmonary vessels are characterized by an increased number of senescent pulmonary artery smooth muscle cells (PA-SMCs). • Senescent PA-SMCs produce soluble and insoluble paracrine factors, which stimulate the growth and migration of normal target PA-SMCs, thereby contributing to pulmonary vessel remodeling.
Conclusion
PA-SMC senescence is an important contributor to the process of pulmonary vascular remodeling that underlies pulmonary hypertension in chronic lung disease.
Orai1-Mediated ICRAC Is Essential for Neointima Formation After Vascular Injury; Zhang et al 33
• Orai1 calcium (Ca2+) channels are expressed in vascular smooth muscle cells (VSMC), and their expression is increased in proliferative migratory "synthetic" VSMC. • Orai1 mediates calcium release-activated calcium (CRAC) current in VSMC that is required for VSMC proliferation and migration in vitro.
What New Information Does This Article Contribute?
• Balloon injury in rat carotids and carotid ligation in mice causes increased expression of Orai1 protein in medial and neointimal VSMC. • Knockdown of Orai1 expression in vivo by transduction of lentivirus-encoding shRNA into balloon-injured carotid arteries prevent Orai1, STIM1, and CamKIIδ2 upregulation, VSMC proliferation in vivo, and neointima formation. • Orai1 knockdown in VSMC inhibits the nuclear translocation and activity of the transcription factor, nuclear factor for activated T-cells (NFAT).
Conclusions
Orai1 is upregulated in VSMC during vascular injury and is required for NFAT activity, VSMC proliferation, and neointima formation following balloon injury of rat carotids. Orai1 provides a novel target for control of VSMC remodeling during vascular injury or disease.
Arteriogenesis Is Modulated By Bradykinin Receptor Signaling; Hillmeister et al 34
What Is Known?
• Arteriogenesis, the growth of preexisting collateral anastomoses, is regulated by changes in hemodynamic forces (eg, increase in pulsatile shear stress on artery occlusion) and inflammatory processes (eg, monocyte invasion). • The bradykinin receptor system is important for vascular biology (eg, increasing the level of tissue kallikrein and kinins protects from vascular ischemia). All components of the kallikrein kinin system can be produced locally in the vasculature. • Bradykinin 1 receptor (B1R) is expressed upon inflammation of vascular cells (endothelium) and bone marrow (BM)-derived cells such as monocytes, dendritic cells, and neutrophils. B1R expression is relevant for neutrophil transmigration into the perivascular tissue.
What New Information Does This Article Contribute?
• Bradykinin receptors are relevant for flow-induced collateral artery growth (arteriogenesis) in the periphery as well as the brain. B1R in particular has a significant long-term impact on arteriogenesis. • Collateral artery growth is critically dependent on the expression of B1R on BM-derived cells. Inhibition of B1R signaling (either in a molecular loss of function model or by pharmacological inhibition) significantly reduces monocyte transmigration during arteriogenesis. • Collateral artery growth can be pharmacologically modulated by application of B1R agonists, which significantly stimulates arteriogenesis. In contrast, application of B1R antagonists significantly inhibits arteriogenesis in the brain and periphery, respectively.
Conclusions
Kinin receptors act as positive modulators of arteriogenesis in mice and rats. B1R can be blocked or therapeutically stimulated by B1R antagonists or agonists, respectively, involving a contribution of peripheral immune cells (monocytes) linking hemodynamic conditions with inflammatory pathways.
Laminin-Binding Integrins Induce Dll4 Expression and Notch Signaling in Endothelial Cells; Estrach et al 35
What Is Known?
• Angiogenesis is a complex process that involves extracellular matrix remodeling, "tip/stalk" population specification, and migration and proliferation of endothelial cells. • Integrins play a crucial role in controlling proliferation and migration in endothelial cells. • Delta-like 4 (Dll4)/Notch participate in the establishment of an adequate balance between tip and stalk cells during angiogenic sprouting.
What New Information Does This Article Contribute?
• Adhesion of endothelial cells to laminin induces Dll4 expression and activates Notch pathway. • The α2β1 and α6β1 integrins, receptors of laminin, specifically trigger intracellular signaling pathways leading to Dll4 induction. • Induction of Dll4 by laminin requires Foxc2-dependent transcription. • Vascular endothelial growth factor (VEGF) stimulates laminin deposition by endothelial cells, leading to specific integrin signaling and subsequent Dll4 expression.
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Conclusions
We show that, in endothelial cells, ligation of α2β1 and α6β1 integrins induces the Notch pathway, and we disclose a novel role of basement membrane proteins in the processes controlling tip vs stalk cell selection.
Calcium Regulates Key Components of Vascular Smooth Muscle Cell-Derived Matrix Vesicles to Enhance Mineralization; Kapustin et al 36
What Is Known
• Vascular smooth muscle cells (VSMCs) are known to be key participants in the initiation of vascular calcification in both the intima and media of the vessel wall. • Dysregulated mineral metabolism leading to increases in calcium and phosphate levels promotes VSMC calcification. • Matrix vesicles released by VSMCs are found at sites of calcification, but the mechanisms whereby these structures promote calcification in response to changes in calcium and phosphate levels are poorly understood.
What New Information Does This Article Contribute?
• Calcification is initiated primarily in matrix vesicles rather than directly on the extracellular matrix. • Dysregulation of intracellular calcium plays an important role in initiating matrix vesicle calcification. • Elevated levels of extracellular calcium initiate matrix vesicle calcification by interfering with inhibitor loading and by promoting the formation of hydroxyapatite nucleation complexes.
Conclusions
In contrast to the coordinated signaling response observed in chondrocyte MVs, mineralization of VSMC-MVs is a pathological response to disturbed intracellular calcium homeostasis that leads to inhibitor depletion and the formation of AnxA6/phosphatidylserine nucleation complexes.
Pannexin1 Regulates α1-Adrenergic Receptor-Mediated Vasoconstriction; Billaud et al 37
• Intercellular communication between smooth muscle cells (SMCs) within the vascular wall is essential for the control of vasoreactivity, but the mechanism for this remains unclear. • Pannexin channels participate in intercellular communication through the release of purines such as ATP, a potent vasoconstrictor.
What New Information Does This Article Contribute?
• Pannexin1 (Panx1) is present in the SMCs of resistant arteries and plays a role in phenylephrine-induced vasoconstriction. • Panx1 and the α1D-adrenergic receptor are part of the same protein complex.
• When phenylephrine binds to the α1D-adrenergic receptor, Panx1 opens to release purines that can act on purinergic receptors present on SMCs to enhance phenylephrine-induced vasoconstriction.
Conclusions
Our data demonstrate for the first time a key role for Panx1 in resistance arteries by contributing to the coordination of vascular smooth muscle cell constriction and possibly to the regulation of blood pressure.
Microparticles in Angiogenesis: Therapeutic Potential [Review]; Martinez & Andriantsitohaina 38
Abstract
Considered during the past decades as cell dust, microparticles are now deemed true biomarkers and vectors of biological information between cells. Depending on their origin, the composition of microparticles varies and the subsequent message transported by them, such as proteins, mRNA, or miRNA, can differ. Recent studies have described microparticles as "cargos" of deleterious information in blood vessel wall under pathological situations such as hypertension, myocardial infarction, and metabolic syndrome. In addition, it has been reported that depending on their origin, microparticles also possess a therapeutic potential regarding angiogenesis. Microparticles can act directly through the interaction ligand/receptor or indirectly on angiogenesis by modulating soluble factor production involved in endothelial cell differentiation, proliferation, migration, and adhesion; by reprogramming endothelial mature cells; and by inducing changes in levels, phenotype, and function of endothelial progenitor cells. This results in an increase in formation of in vitro capillary-like tubes and the generation of new vessels in vivo under ischemic conditions, for instance. Taking into consideration these properties of microparticles, recent evidence provides new basis to expand the possibility that microparticles might be used as therapeutic tools in pathologies associated with an alteration of angiogenesis.
Cell-Matrix Interactions in the Pathobiology of Calcific Aortic Valve Disease: Critical Roles for Matricellular, Matricrine, and Matrix Mechanics Cues [Review]; Chen & Simmons 39
Abstract
The hallmarks of calcific aortic valve disease (CAVD) are the significant changes that occur in the organization, composition, and mechanical properties of the extracellular matrix (ECM), ultimately resulting in stiffened stenotic leaflets that obstruct flow and compromise cardiac function. Increasing evidence suggests that ECM maladaptations are not simply a result of valve cell dysfunction; they also contribute to CAVD progression by altering cellular and molecular signaling. In this review, we summarize the ECM changes that occur in CAVD. We also discuss examples of how the ECM influences cellular processes by signaling through adhesion receptors (matricellular signaling), by regulating the presentation and availability of growth factors and cytokines to cells (matricrine signaling), and by transducing externally applied forces and resisting cell-generated tractional forces (mechanical signaling) to regulate a wide range of pathological processes, including differentiation, fibrosis, calcification, and angiogenesis. Finally, we suggest areas for future research that should lead to new insights into bidirectional cell-ECM interactions in the aortic valve, their contributions to homeostasis and pathobiology, and possible targets to slow or prevent the progression of CAVD.
Intermittent Hypoxia in Rats Increases Myogenic Tone Through Loss of Hydrogen Sulfide Activation of Large-Conductance Ca2+-Activated Potassium Channels; Jackson-Weaver et al 40
• Intermittent hypoxia (IH) is a model for sleep apnea-induced hypertension, and is associated with vascular dysfunction and elevated blood pressure in rats. • Myogenic tone is a pressure-induced constriction of blood vessels that can be an important regulator of arterial resistance. • Hydrogen sulfide (H2S) is a recently described endothelium-derived vasodilator that is responsive to hypoxia.
What New Information Does This Article Contribute?
• H2S causes vasodilation in small mesenteric arteries through the activation of large-conductance Ca2+-activated K+ channels (BKCa). • H2S dilation normally inhibits myogenic tone in small mesenteric arteries, but loss of H2S production after IH exposure leads to increased myogenic tone. • IH vascular smooth muscle cells (VSMC) are depolarized in relation to control cells because of this loss of H2S.
Conclusions
IH appears to decrease endothelial CSE expression to reduce H2S production, depolarize VSM, and enhance myogenic tone. H2S dilatation and hyperpolarization of VSM in small mesenteric arteries requires BKCa channels.
Thematic Series on the Pathobiology of Vascular Calcification: An Introduction [Review]; Towler & Demer 41
Abstract Vascular calcification increasingly afflicts our aging, dysmetabolic population. Once considered only a passive process of dead and dying cells, data from multiple laboratories worldwide have converged to demonstrate that vascular calcification is a highly regulated form of biomineralization. The goal of this thematic review series is to highlight what is known concerning the biological "players" and "game rules" with respect to vascular mineral metabolism. Armed with this understanding, it is hoped that novel therapeutic strategies can be crafted to prevent and treat vascular calcium accrual, to the benefit of our patients afflicted with arteriosclerotic valvular and vascular diseases.
The Transcription Factor HOXC9 Regulates Endothelial Cell Quiescence and Vascular Morphogenesis in Zebrafish via Inhibition of Interleukin 8; Stoll et al 42
• The vascular system is the first organ formed during embryonic development. • Transcription factors regulate several processes important for vascular development, such as endothelial cell formation, differentiation, vessel maturation and remodeling, arteriovenous differentiation, and lymphatic patterning. • HOX genes act as essential transcriptional regulators for spatial body development. • HOXC9 is expressed in different vascular beds in vivo.
What New Information Does This Article Contribute?
• HOXC9 is abundantly expressed in resting endothelial cells and is downregulated by hypoxia. • HOXC9 inhibits endothelial cell proliferation, migration, and tube formation in vitro in an interleukin 8-dependent manner. • HOXC9 binds directly to the interleukin 8 promotor and acts as a transcriptional repressor of interleukin 8. • In zebrafish, endothelial-specific overexpression of HOXC9 or the loss of interleukin 8 inhibits vascular morphogenesis. • Vascular developmental defects mediated by HOXC9 can be rescued by interleukin 8 in zebrafish.
Conclusion
The data identify HOXC9 as an endothelial cell active transcriptional repressor promoting the resting, antiangiogenic endothelial cell phenotype in an interleukin 8-dependent manner.
Orai1 and CRAC Channel Dependence of VEGF-Activated Ca2+ Entry and Endothelial Tube Formation; Li et al 43
What Is Known?
• Orai1 is a T-cell membrane protein component of a Ca2+ entry mechanism that is defective in severe combined immune deficiency. • Depletion of intracellular Ca2+ stores is an activation signal for calcium release-activated calcium (CRAC) channels in T cells. • Orai1 is expressed in human umbilical vein endothelial cells, which contain CRAC channel-like signals.
What New Information Does This Article Contribute?
• Endothelial Orai1 stimulates Ca2+ entry, cell migration, and tube formation evoked by vascular endothelial growth factor (VEGF). • A specific chemical blocker of CRAC channels inhibits VEGF-evoked Ca2+ entry, endothelial cell migration, and endothelial tube formation in vitro, and angiogenesis in vivo.
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• Endothelial Ca2+ entry is more sensitive to CRAC channel blockade than immune cell Ca2+ entry.
Conclusions
The data suggest positive roles for Orai1 and CRAC channels in VEGF-evoked calcium entry and new opportunity for chemical modulation of angiogenesis.
SIRT1 Acts as a Modulator of Neointima Formation Following Vascular Injury in Mice; Li et al 44
• Vascular smooth muscle cell (VSMC) proliferation and migration are crucial events in the development of vascular diseases. • SIRT1 has been reported to exert functions that antagonize atherosclerosis, but its role in neointimal formation is unknown.
What New Information Does This Article Contribute?
• SIRT1 expression is downregulated by vascular injury.
• SIRT1 represses neointima formation in response to carotid ligation and carotid artery wire injury. • SIRT1 inhibits VSMC proliferation and migration.
• SIRT1 represses AP-dependent transcriptional regulation of cyclin D1 and MMP-9.
Conclusions
Our findings demonstrate the inhibitory effect of SIRT1 on the VSMC proliferation and migration that underlie neointima formation and implicate SIRT1 as a potential target for intervention in vascular diseases.
The Actin-Binding Protein Girdin and Its Akt-Mediated Phosphorylation Regulate Neointima Formation After Vascular Injury; Miyake et al 45
• Akt signaling pathway is known to have a pivotal role in neointima formation after vascular injury. • The actin-binding protein Girdin is a novel Akt substrate that regulates cell motility.
What New Information Does This Article Contribute?
• Girdin is essential for motility and proliferation of vascular smooth muscle cells (VSMCs). • Girdin expression and phosphorylation are required for neointima formation after vascular injury. • The Akt/Girdin signaling pathway is crucial for vascular remodeling process.
Conclusions
These findings indicate that Girdin and its Akt-mediated phosphorylation have major roles in the migration and proliferation of VSMCs and vascular remodeling, making the Akt/Girdin signaling pathway a potential target for the development of new therapeutics for vascular diseases.
Existence of an Endogenous Circadian Blood Pressure Rhythm in Humans That Peaks in the Evening; Shea et al 46
• Numerous epidemiological studies have shown a profound morning increase in the incidence of adverse cardiovascular events, including sudden cardiac death, ventricular arrhythmia, stroke, and myocardial infarction. • A primary risk factor for adverse cardiovascular events is elevated arterial blood pressure (BP), which usually decreases during nocturnal sleep and increases during daytime activities. • The endogenous circadian timing system orchestrates daily rhythms in physiology (regardless of ongoing behaviors such as sleep and wake cycle) and could potentially contribute to the day/night pattern of changing BP.
What New Information Does This Article Contribute?
• The data show presence of a robust endogenous circadian rhythm in BP. • The highest BP occurred at the circadian time corresponding to ≈9 pm, suggesting that the endogenous BP rhythm is unlikely to underlie the well-documented morning peak in adverse cardiovascular events. • The endogenous circadian evening peaks in systolic and diastolic BP did not appear to be mechanistically linked with the endogenous ≈24 rhythmicity of numerous variables that would be expected to correlate in the short term with acute changes in BP, including cortisol, catecholamines, cardiac vagal modulation, and heart rate.
Conclusions
There exists a robust endogenous circadian rhythm in BP. The highest BP occurred at the circadian time corresponding to ≈9:00 pm, suggesting that the endogenous BP rhythm is unlikely to underlie the well-documented morning peak in adverse cardiovascular events.
insights into PPAR-RXRs may help inform interpretation of clinical trials with synthetic PPAR agonists and prospects for future PPAR therapeutics. Importantly, the extensive data establishing a key role for PPARs and RXRs in energy balance, inflammation, and vascular biology stands separately from the clinical experience with any given synthetic PPAR agonist. Both the basic science data and the clinical experience with PPAR agonists identify the need to better understand these important transcriptional regulators.
Ablation of the Leptin Receptor in the Hypothalamic Arcuate Nucleus Abrogates Leptin-Induced Sympathetic Activation; Harlan et al 48
What Is Known?
• Leptin is an adipocyte-derived hormone that is crucial for the regulation of body weight. • Activation of the sympathetic nervous system by leptin increases blood pressure. • Obesity is associated with selective leptin resistance (eg, intact cardiovascular effects of leptin despite loss of its metabolic actions). • Leptin receptors are located in different regions of the brain regions; highest levels are found in the hypothalamic arcuate nucleus.
What New Information Does This Article Contribute?
• Arcuate nucleus-specific disruption of leptin receptors abolishes the sympathetic effects of leptin and lowers elevated blood pressure. • The arcuate nucleus mediates sympathetic and cardiovascular effects of leptin in obesity.
Conclusions
These data demonstrate a critical role for ObR in the ARC in mediating the sympathetic nerve responses to leptin and in the adverse sympathoexcitatory effects of leptin in obesity.
Chronic Fine Particulate Matter Exposure Induces Systemic Vascular Dysfunction via NADPH Oxidase and TLR4 Pathways; Kampfrath et al 49
What Is Known?
• Chronic exposure to PM2.5 (particulate matter of <2.5 μm) is associated with heightened risk for cardiovascular events. • The mechanisms are believed to involve inflammatory responses triggered by PM2.5. However, the locus, differential contribution of the lung, and the pathways remain poorly defined.
What New Information Does This Article Contribute?
• Identification of monocyte subsets (Ly6Chigh) that increase in response to chronic inhalational PM2.5 exposure. • TLR4 and Nox2 mitigates the systemic effects of chronic PM2.5 exposure.
• Chronic PM2.5 exposure increases oxidized phospholipid derivatives of 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine in bronchioalveolar lavage fluid. • Exposure of bone marrow-derived macrophages to oxPAPC but not PAPC recapitulated effects of chronic PM2.5 exposure, whereas TLR4 deficiency attenuated this response.
Conclusions
Taken together, our findings suggest that PM2.5 triggers an increase in oxidized phospholipids in lungs that then mediates a systemic cellular inflammatory response through TLR4/ NADPH oxidase-dependent mechanisms.
Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor −/− Mice; Rateri et al 50
What Is Known?
• Ang II infusion promotes profound aortic dilation that is restricted to the ascending portion. • AT1b receptors have functional effects in aortic tissue.
What New Information Does This Article Contribute?
• Whole body deficiency of AT1a receptors ablates the development of ascending AAs.
• Depletion of AT1a receptors on bone marrow-derived cells
or SMCs has no effect on Ang II-induced ascending AAs. • Depletion of AT1a receptors on endothelial cells markedly attenuates ascending aortic dilation.
Conclusions
Ang II infusion promotes aneurysms in the ascending aorta via stimulation of AT1a receptors that are expressed on endothelial cells.
H2O2 Is the Transferrable Factor Mediating Flow-Induced Dilation in Human Coronary Arterioles; Liu et al 51
What Is Known?
• Nitric oxide (NO), prostaglandin (PG)I2, and metabolites of arachidonic acid play an important role in mediating vasodilation induced by blood flow in normal arteries. • Flow-mediated dilation (FMD) occurs in coronary arterioles in patients with coronary disease via a different mechanism requiring production of hydrogen peroxide (H2O2). • H2O2 elicits non-NO and non-PGI2-induced smooth muscle hyperpolarization and relaxation in both animals and humans.
What New Information Does This Article Contribute?
• Endothelial H2O2 is the endothelium-derived transferrable hyperpolarizing factor stimulated by flow that evokes hyperpolarization and relaxation in smooth muscle cells by a paracrine mechanism. e264 Circulation Research October 26, 2012
• H2O2-induced hyperpolarization and vasodilation result from the opening of large conductance Ca2+-activated K+ (BKCa) channels in the smooth muscle membrane.
Conclusions
Flow induced endothelial production of H2O2, which acts as the transferrable EDHF activating BKCa channels on the smooth muscle cells.
Vascular Smooth Muscle Progenitor Cells: Building and Repairing Blood Vessels [Review]; Majesky et al 52
Abstract
Molecular pathways that control the specification, migration, and number of available smooth muscle progenitor cells play key roles in determining blood vessel size and structure, capacity for tissue repair, and progression of agerelated disorders. Defects in these pathways produce malformations of developing blood vessels, depletion of smooth muscle progenitor cell pools for vessel wall maintenance and repair, and aberrant activation of alternative differentiation pathways in vascular disease. A better understanding of the molecular mechanisms that uniquely specify and maintain vascular smooth muscle cell precursors is essential if we are to use advances in stem and progenitor cell biology and somatic cell reprogramming for applications directed to the vessel wall.
Endothelial Nitric Oxide Modulates Expression and Processing of Amyloid Precursor Protein; Austin et al 53
What Is Known?
• Amyloid precursor protein (APP) is the parent molecule that when sequentially cleaved by β-site APP cleaving enzyme 1 (BACE1) and γ-secretase generates the amyloid β (Aβ) peptide which is the primary component of Alzheimer's disease (AD) plaques. • Cardiovascular risk factors such as hypertension, hypercholsterolemia, diabetes mellitus, aging and a sedentary lifestyle are associated with a higher incidence of AD. • Endothelial dysfunction caused by decreased bioavailability of nitric oxide (NO) is a common feature among cardiovascular risk factors.
What New Information Does This Article Contribute?
• Endothelial-derived NO suppresses APP, BACE1 and Aβ by increasing cyclic guanosine monophosphate (cGMP) in brain microvascular endothelial cells (BMECs). • Endothelial nitric oxide synthase (eNOS) deficient (eNOS−/−) mice display increased APP, BACE1, and Aβ peptide in brain tissue and increased BACE1 protein levels in the cerebral microvasculature when compared with wildtype control mice. • NO-mediated effects were specific to APP and BACE1 as there were no differences in the other secretase enzymes or Aβ-degradation enzymes between eNOS−/− and wild-type l mice.
Conclusions
Our data suggest that endothelial NO plays an important role in modulating APP expression and processing within the brain and cerebrovasculature. The NO/cGMP pathway may be an important therapeutic target in preventing and treating mild cognitive impairment, as well as AD.
The Mechanical Stress-Activated Serum-, Glucocorticoid-Regulated Kinase 1 Contributes to Neointima Formation in Vein Grafts; Cheng et al 54
• Vein graft failure is commonly associated with neointima formation. • Mechanical stretch induces vascular smooth muscle cell (VSMCs) proliferation. • Expression and activation of growth signals are involved in neointimal formation.
What New Information Does This Article Contribute?
• SGK-1 (serum-, glucocorticoid-regulated kinase-1) is a mechanosensitive, growth-promoting kinase. Mechanical stretch stimulates the expression and activation of SGK-1 in VSMCs. • Knockout of SGK-1 suppresses neointima formation and preserves vein graft patency in mice.
Conclusions
These results suggest that SGK-1 is an injury-responsive kinase that could mediate mechanical stretch-induced proliferation of vascular cells in vein graft, leading to neointima formation.
The Role of Wnt Signaling in Physiological and Pathological Angiogenesis [Review]; Dejana 55
Abstract
Early stages of vascular development include endothelial cell differentiation in a network of arteries, veins, and lymphatics. Subsequently, to respond to the specific needs of the organs, endothelial cells acquire specialized properties such as permeability control, expression of specific transcellular transport systems, membrane adhesive molecules, and others. Endothelial cell differentiation depends on communication between the surrounding tissues, which is mediated by growth and differentiation factors able to activate specific gene expression programs. Recent reports underline the important role of the Wnt system in vascular morphogenesis in the embryo and in organ-specific endothelial differentiation. Wnt signaling regulates fundamental aspects of development, including cell fate specification, proliferation, and survival, and may use different receptors and signaling pathways. Both loss-and gain-of-function experiments of members of the Wnt signaling pathway were found to cause marked alterations of vascular development and endothelial cell specification. Furthermore, altered Wnt signaling in the endothelium may contribute to pathological conditions such as retinopathies, pulmonary arterial hypertension, stroke, and others. Continued progress in this field holds the
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Involvement of the Brain (Pro)renin Receptor in Cardiovascular Homeostasis; Shan et al 56
• (Pro)renin receptor (PRR) is a new member of renin-angiotensin (RAS) system. • PRR can bind either renin or prorenin, and this binding facilitates angiotensin II generation and stimulates signal transduction in the periphery.
What New Information Does This Article Contribute?
• PRR is more highly expressed in the supraoptic nucleus (SON) of spontaneously hypertensive rats (SHRs) than in normotensive Wistar-Kyoto (WKY) rats. • Overexpression of PRR in the SON increases vasopressin (AVP) secretion and alters fluid balance in normal rats. • Knockdown of this receptor significant attenuates the agedependent increases in blood pressure and causes a decrease in heart rate in the SHRs.
Conclusions
The study demonstrates that brain PRR is functional and plays a role in the neural control of cardiovascular functions. This may help resolve a long-held controversy concerning the existence of intrinsic and functional brain RAS.
Sphingosine-1-Phosphate-Dependent Activation of p38 MAPK Maintains Elevated Peripheral Resistance in Heart Failure Through Increased Myogenic Vasoconstriction; Hoefer et al 57
What Is Known?
• In heart failure, an increase in peripheral resistance maintains an acceptable blood pressure despite diminished cardiac output but increases the afterload against which the compromised heart must work. • The myogenic response, a primary intrinsic mechanism that regulates resistance artery tone, is augmented in heart failure.
What New Information Does This Article Contribute?
• Increased myogenic responsiveness in heart failure results from an upregulation of microvascular sphingosine-1-phosphate (S1P) signaling, which, in turn, activates the extracellular signal-regulated kinase (ERK)1/2 and p38 mitogen-activated protein kinase (MAPK) pathways that ultimately inhibit myosin light chain phosphatase. • Microvascular S1P signaling is a potential therapeutic target for the control of peripheral resistance in heart failure.
Conclusions
Rho-independent p38 MAPK-mediated deactivation of MLCP underlies S1P/S1P2R-regulated increases in myogenic vasoconstriction observed in HF. Therapeutic targeting of these findings in HF models deserves study.
Vascular Smooth Muscle Cell Stiffness As a Mechanism for Increased Aortic Stiffness With Aging; Qiu et al 58
• One of the most significant cardiovascular changes with aging is increased arterial pulse pressure, which is attributable to increased stiffness of large arteries, eg, the aorta. • Considered an important risk factor, it is widely held that the increased aortic stiffness observed with aging is attributable to changes in the extracellular matrix (ECM), ie, increase in collagen and decrease in elastin. • There is virtually no information on whether changes in the mechanical properties of vascular smooth muscle cells (VSMCs) can contribute to the increased stiffness of the aorta with aging.
What New Information Does This Article Contribute?
• The increased aortic stiffness of aging is due not only to changes in the ECM but also to increases in stiffness of the VSMCs. • This novel mechanism for vascular stiffness may also be involved in the increased aortic stiffness observed in hypertension, atherosclerosis, and aortic aneurysm. • Targeting the mechanisms that regulate VSMC stiffness could be a novel therapeutic approach for these diseases.
Conclusions
These data support the novel concept, not appreciated previously, that increased vascular stiffness with aging is attributable not only to changes in ECM but also to intrinsic changes in VSMCs.
Elastin Haploinsufficiency Results in Progressive Aortic Valve Malformation and Latent Valve Disease in a Mouse Model; Hinton et al 59
What Is Known?
• Valve disease is characterized by extracellular matrix (ECM) and valve interstitial cell (VIC) abnormalities. • Animal models of valve disease are limited.
What New Information Does This Article Contribute?
• The present study provides a genetic mouse model of latent valve disease that has origins in development. • The present study identifies elastin as a crucial factor in aortic valve disease pathogenesis. • The present study implicates the valve annulus region in disease manifestation.
Conclusions
These results identify the Eln+/− mouse as a model of latent aortic valve disease and establish a role for elastin dysregulation in valve pathogenesis.
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Nitro-Oleic Acid Inhibits Angiotensin II-Induced Hypertension; Zhang et al 60
• Nitroalkenes are nitric oxide derivatives of unsaturated fatty acids with pleiotropic biological activities of relevance for metabolic and cardiovascular diseases. • Nitro-oleic acid (OA-NO2) protects against vascular lesion, atherosclerosis, cardiac ischemia/reperfusion injury, and diabetes in experimental animal models.
What New Information Does This Article Contribute?
• OA-NO2 reduces blood pressure and vasoconstriction in response to angiotensin (Ang) II. • OA-NO2 binds Ang II receptor (AT1R), but it does not interfere with Ang II binding to the receptor unlike typical competitive angiotensin receptor blockers, thus defining a novel mechanism for antagonism. • OA-NO2 and rosiglitazone reduce established hypertension through different pathways. • Inhibition of AT1R by OA-NO2 uncouples downstream G-protein signaling and calcium mobilization.
Conclusions
These results demonstrate that OA-NO2 diminishes the pressor response to Ang II and inhibits AT1R-dependent vasoconstriction, revealing OA-NO2 as a novel antagonist of Ang II-induced hypertension.
VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling; Zhang et al 61
What Is Known?
• Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis, leukemic cell growth, and inflammation. • Vascular remodeling is a common feature of many vascular diseases, including graft arteriosclerosis and postangioplasty restenosis. • Interferon-γ plays a nonredundant role in the development of graft arteriosclerosis.
What New Information Does This Article Contribute?
• VEGF blockade inhibits neointima formation in immunemediated vascular remodeling, at least in part, through a reduction in T-cell accumulation in the neointima. • A subset of T cells expresses functional VEGF receptor-1.
• VEGF enhances T-cell capture by the activated endothelium under flow conditions.
Conclusions
VEGF contributes to vascular remodeling in human arteries through a direct effect on human T cells that enhances their recruitment to the vessel. These findings raise the possibility of novel therapeutic approaches to vascular remodeling based on inhibition of VEGF signaling.
Central and Peripheral Mechanisms of T-Lymphocyte Activation and Vascular Inflammation Produced by Angiotensin II-Induced Hypertension; Marvar et al 62
• We have previously shown that T cells are essential for development of hypertension. • The circumventricular organs in the CNS are key targets for the peptide angiotensin II and are essential in the regulation of blood pressure.
What New Information Does This Article Contribute?
• Central effects of angiotensin II are required for T-cell activation and peripheral vascular inflammation in the setting of hypertension caused by this octapeptide. • Modest elevations of blood pressure mediated by central stimuli promote inflammation, which leads to severe hypertension in a feed-forward fashion.
Conclusions
We conclude that the central and pressor effects of angiotensin II are critical for T-cell activation and development of vascular inflammation. These findings also support a feed-forward mechanism in which modest degrees of blood pressure elevation lead to T-cell activation, which in turn promotes inflammation and further raises blood pressure, leading to severe hypertension.
Smad-Dependent and Smad-Independent Induction of Id1 by Prostacyclin Analogues Inhibits Proliferation of Pulmonary Artery Smooth Muscle Cells In Vitro and In Vivo; Yang et al 63
What Is Known?
• Mutations in the bone morphogenetic protein type II receptor (BMPR-II) are a major cause of pulmonary arterial hypertension (PAH). • Loss of BMPR-II signaling leads to a failure of growth suppression of pulmonary artery smooth muscle cells (PASMCs). • Prostanoids inhibit PASMC proliferation in vitro and are effective treatments for patients with PAH.
What New Information Does This Article Contribute?
• Prostanoids enhance BMP signaling in normal PASMCs and restore BMP signaling in BMPR-II mutant PASMCs. • Prostanoids inhibit the proliferation of PASMCs in vitro and in vivo via the induction of BMP signaling pathways. • Rescue of specific BMP signaling pathways indicates a novel mechanism of action of prostanoids and identifies further potential therapeutic targets for PAH.
Conclusions
Prostacyclin analogues enhance Id1 expression in vitro and in vivo and restore deficient BMP signaling in BMPR-II mutant PASMCs.
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Increased Endothelial Exocytosis and Generation of Endothelin-1 Contributes to Constriction of Aged Arteries; Goel et al 64
What Is Known?
• Studies in cultured endothelial cells have demonstrated that endothelin (ET)-1 is released both continuously via a constitutive pathway and rapidly in response to stimulated exocytosis, suggesting storage of ET-1 or its precursors in endothelial storage granules such as Weibel-Palade Bodies. • ET-1, which can cause oxidant stress, endothelial dysfunction, vascular inflammation, vascular constriction and vascular remodeling, has increased activity in aging individuals and likely contributes to age-related cardiovascular dysfunction. • No previous studies have directly assessed the stimulated endothelial exocytosis of ET-1 or other mediators from native arteries or its potential modulation in the aging vasculature.
What New Information Does This Article Contribute?
• Stimulation of endothelium caused rapid exocytotic release of ET-1 from aged but not young arteries, and the released ET-1 contributed to constriction of aged arteries. • The generation of ET-1 in aging arteries occurred during the exocytotic process and reflected rapid conversion of its precursor Big ET-1 by endothelin-converting enzyme (ECE)-1, both of which had increased expression in aged endothelium. • Aging also increased the excitability of the exocytotic process because of a decreased sensitivity of aging endothelium to the inhibitory effects of nitric oxide, resulting in increased stimulated exocytosis of stored mediators from aging endothelium.
Conclusions
The stimulated exocytotic release of ET-1 is dramatically increased in aged endothelium. This reflects increased reactivity of exocytosis, increased expression and storage of ET-1 precursor peptides, and increased expression of ECE-1. Altered endothelial exocytosis of ET-1 and other mediators may contribute to cardiovascular pathology in aging.
Episodic Exposure to Fine Particulate Air Pollution Decreases Circulating Levels of Endothelial Progenitor Cells; O'Toole et al 65
What Is Known?
• Several epidemiological studies show that acute exposure to elevated levels of fine airborne particulate matter is associated with an increase in the risk of adverse cardiovascular events. • Controlled laboratory exposure to particulate matter has been reported to induce acute conduit artery vasoconstriction in humans and chronic deficits in endothelium-mediated vasodilation in mice. • Endothelial progenitor cells (EPCs) in peripheral blood contribute to postembryonic endothelial repair and regeneration and a decrease in circulating EPC levels is reflective of cardiovascular disease risk and burden.
What New Information Does This Article Contribute?
• An increase in airborne particulate matter attributable to winter temperature inversion-episode in Utah Valley of the Wasatch Front was associated with a reversible decrease in circulating levels of EPC in a cohort of young (18 to 25 years) healthy adults. • The increase in particulate matter was also accompanied by an increase in plasma levels of platelet-monocyte aggregates, high-density lipoprotein, and nonalbumin protein.
No changes in C-reactive protein, interleukin-1β, interleukin-6, fibrinogen, or serum amyloid A were observed. • Circulating levels of EPC were also decreased in mice exposed to concentrated airborne particles from downtown Louisville, Ky.
Conclusions
Episodic exposure to PM2.5 induces reversible vascular injury, reflected in part by depletion of circulating EPC levels, and increases in platelet activation and the plasma level of high-density lipoprotein. These changes were also accompanied by an increase in nonalbumin protein and may be related to mechanisms by which exposure to particulate air pollution increases the risk of cardiovascular disease and adverse cardiovascular events.
Farnesoid X Receptor Activation Prevents the Development of Vascular Calcification in ApoE−/− Mice With Chronic Kidney Disease; Miyazaki-Anzai et al 66
What Is Known?
• Vascular calcification is the leading cause of death in patients with chronic kidney disease (CKD). • The bile acid nuclear receptor farnesoid X receptor (FXR) controls bile acid, lipid, and glucose metabolism and is expressed in vascular cells including vascular smooth muscle cells and endothelial cells. • FXR activation by synthetic agonists protects mice from a variety of metabolic diseases such as liver steatosis, insulin resistance, hyperlipidemia, cholestasis, diabetic nephropathy, and atherosclerosis; however, its role in vascular calcification is unknown.
What New Information Does This Article Contribute?
• Vascular FXR is highly induced during vascular calcification. 
Conclusions
These observations provide direct evidence that FXR is a key signaling component in regulation of vascular osteogenic 
What Is Known?
• Vascular cells possess multiple Nox isoforms, including Nox1, Nox2, Nox4, and the recently identified Nox5, all of which have been implicated as major enzymatic sources of reactive oxygen species (ROS) in the vasculature. • Unlike other Noxs, Nox5 is unique in that it is possesses an amino-terminal calmodulin-like domain with 4 binding sites for Ca2+ (EF hands); it does not require p22phox or other subunits for its activation and its gene is absent in rodents. • Binding of Ca2+ to Nox5 induces a conformational change, leading to oxidase activation and superoxide generation, implicated in cellular processes associated with angiogenesis and atherosclerosis.
What New Information Does This Article Contribute?
• Vasoactive agonists that increase [Ca2+]i, such as angiotensin II (Ang II) and endothelin-1 (ET-1), induce activation of Nox5 through Ca2+-sensitive, calmodulin-dependent and Rac-1-independent processes in human endothelial cells. • Nox5 signaling by Ang II and ET-1 involves ROS and ERK1/2, but not p38MAPK or SAPK/JNK. • Although Ang II and ET-1 both signal through Nox5-ROS-ERK1/2 pathways, the functional responses differ: Nox5 is important in redox-sensitive growth and inflammation mediated by Ang II, but not by ET-1.
Conclusions
Human ECs possess functionally active Nox5, regulated by Ang II and ET-1 through Ca2+/calmodulin-dependent, Rac-1independent mechanisms. Nox5 activation by Ang II and ET-1 induces ROS generation and ERK1/2 phosphorylation. Nox5 is involved in ERK1/2-regulated growth and inflammatory signaling by Ang II but not by ET-1. We elucidate novel mechanisms whereby vasoactive peptides regulate Nox5 in human ECs and demonstrate differential Nox5-mediated functional responses by Ang II and ET-1. Such phenomena link Ca2+/ calmodulin to Nox5 signaling, potentially important in the regulation of endothelial function by Ang II and ET-1.
Lung Endothelial Dysfunction in Congestive Heart Failure: Role of Impaired Ca2+ Signaling and Cytoskeletal Reorganization; Kerem et al 68
• The majority of patients with congestive heart failure develop secondary pulmonary hypertension. • Pulmonary hypertension owing to left heart disease is frequently aggravated by a reactive increase in pulmonary vascular resistance.
• Congestive heart failure causes lung endothelial dysfunction which may trigger this increase in lung vascular resistance, yet underlying mechanisms are unclear.
What New Information Does This Article Contribute?
• Endothelial-dependent vasodilation and NO synthesis are impaired in lungs of rats with congestive heart failure. • Lung endothelial dysfunction in heart failure constitutes the functional consequence of a fundamental impairment in endothelial Ca2+ signaling. • The impaired Ca2+ signaling is attributable to a massive remodeling of the endothelial cytoskeleton.
Conclusions
Our findings characterize a unique scenario of endothelial dysfunction in CHF that is caused by a singular impairment of [Ca2+]i signaling, and identify cytoskeletal reorganization as a major regulator of endothelial signaling and function.
Transmural Dispersion of Repolarization in Failing and Nonfailing Human Ventricle; Glukhov et al 69
• Numerous animal models have demonstrated that the left ventricular transmural dispersion of repolarization plays an important role in normal physiology and pathophysiology. • Canine and other animal models of heart failure have showed significant proarrhythmic electrophysiological remodeling, associated with an increased ventricular transmural heterogeneity in cell-cell coupling and in repolarization. • The clinical relevance of these findings, however, has been challenged given the lack of similar findings in human studies that have been published thus far.
What New Information Does This Article Contribute?
• There is a significant transmural gradient of repolarization in the left ventricle of the normal human heart at physiological heart rates. • Heart failure results in prolongation of action potential duration and overall reduction of transmural gradient of repolarization in the human left ventricle. • Heart failure leads to significant downregulation of connexin 43 in the left ventricular subepicardium.
Conclusions
We present for the first time direct experimental evidence of a transmural APD gradient in the human heart. HF results in the heterogeneous prolongation of APD, which significantly reduces the transmural and local APD gradients.
Transmural Flow Modulates Cell and Fluid Transport Functions of Lymphatic Endothelium; Miteva et al 70
What Is Known?
• Lymphatic transport of dendritic cells and fluid from the periphery to the lymph node is important in injury and inflammation. • Lymphatic drainage (fluid flow) can be rapidly increased on injury or inflammation.
• There is no knowledge to date on whether or little understanding how fluid flow can modulate lymphatic transport functions.
What New Information Does This Article Contribute?
• This is the first demonstration that lymphatic endothelium is sensitive to transmural fluid flow and modulates fluid and dendritic cell transport functions in response. • This article introduces the concept that biophysical aspects of inflammation (ie, elevated transmural flow from blood to lymphatic capillaries) can directly regulate lymphatic biology, even in the absence of inflammatory mediators.
Conclusions
These findings introduce transmural flow as an important regulator of lymphatic endothelial function and suggest that flow might serve as an early inflammatory signal for lymphatics, causing them to regulate transport functions to facilitate the delivery of soluble antigens and DCs to lymph nodes.
Epicardial-Myocardial Signaling Directing Coronary Vasculogenesis [Review]; Olivey & Svensson 71
Abstract
The establishment of the coronary circulation is critical for the development of the embryonic heart. Over the last several years, there has been tremendous progress in elucidating the pathways that control coronary development. Interestingly, many of the pathways that regulate the development of the coronary vasculature are distinct from those governing vasculogenesis in the rest of the embryo. It is becoming increasingly clear that coronary development depends on a complex communication between the epicardium, the subepicardial mesenchyme, and the myocardium mediated in part by secreted growth factors. This communication coordinates the growth of the myocardium with the formation of the coronary vasculature. This review summarizes our present understanding of the role of these growth factors in the regulation of coronary development. Continued progress in this field holds the potential to lead to novel therapeutics for the treatment of patients with coronary artery disease.
Angiotensin II Inhibits Neuronal Nitric Oxide Synthase Activation Through the ERK1/2-RSK Signaling Pathway to Modulate Central Control of Blood Pressure; Cheng et al 72
• The renin-angiotensin system has been reported to play an important role in the development of hypertension. • Reactive oxygen species participate in central autonomic networks that are involved in Ang II-mediated signaling. • NO participates in blood pressure control in the NTS.
What New Information Does This Article Contribute?
• nNOS is a key downstream target of Ang II that is involved in NO production and regulates blood pressure in the NTS of spontaneously hypertensive rats.
• The ERK1/2-RSK-nNOS pathway participates in central blood pressure regulation by Ang II in SHRs. • Ang II may elevate central blood pressure through reactive oxygen species production to block ERK1/2-RSK-nNOS activity.
Conclusions
Taken together, these results suggest that the ERK1/2-RSK-nNOS signaling pathway may play a significant role in Ang II-mediated central blood pressure regulation.
Potential Mechanisms of Low Sodium Diet-Induced Cardiac Disease: Superoxide-NO in the Heart; Suematsu et al 73
What Is Known?
• A low salt diet is used in the treatment of heart failure and hypertension. • A low salt diet is thought to have beneficial effects in most patients except that in a subgroup of patients a low salt diet actually increases mortality. • Angiotensin drives the production of superoxide from NADPH oxidase and the increase in superoxide production is thought to be part of many disease processes.
What New Information Does This Article Contribute?
• This article documents the reduction in nitric oxide bioavailability in a high superoxide state attributable to the rise in angiotensin during low salt feeding. • Thus, an upregulation of the components of the NADPH oxidase make an important contribution to the development of disease. • Our article contributes to the better understanding of the mechanism of action of the detrimental effects of a low salt diet, including activation of the renin angiotensin system and the generation of superoxide.
Conclusions
LS diet induces the activation of the renin-angiotensin system, which increases oxidative stress via the NADPH oxidase and attenuates NO bioavailability in the heart.
Overexpression of Dimethylarginine Dimethylaminohydrolase Protects Against Cerebral Vascular Effects of Hyperhomocysteinemia; Rodionov et al 74
What Is Known?
• Homocysteine is a risk factor for cardiovascular disease, yet homocysteine-lowering therapy does not improve clinical outcomes. • Homocysteine might be a biomarker of another risk factor, such as ADMA. • ADMA levels are regulated by the enzyme DDAH.
What New Information Does This Article Contribute?
• Overexpression of DDAH protects from some of the deleterious vascular effects of homocysteine in a mouse model.
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• The ADMA/DDAH metabolic pathway may be a promising therapeutic target in cardiovascular disease.
Conclusions
Overexpression of DDAH1 protects from hyperhomocysteinemia-induced alterations in cerebral arteriolar structure and vascular muscle function.
Chemoreceptor Hypersensitivity, Sympathetic Excitation, and Overexpression of ASIC and TASK Channels Before the Onset of Hypertension in SHR; Tan et al 75
What Is Known?
• Increased SNA is an essential component of the pathogenesis of hypertension. • Chemoreceptor hyperactivity can increase SNA in hypertension.
What New Information Does This Article Contribute?
• Increased chemoreceptor sensitivity is a cause of increased SNA in a genetic model of hypertension (the SHR) before the onset of hypertension. • The cellular mechanism involves a hypersensitivity of the chemotransducing carotid body type 1 glomus cell to low pH. • The molecular determinants include the overexpression of acid sensitive ion channels ASIC and TASK in the carotid bodies which initiate a prehypertensive increase in SNA and may cause the development of hypertension.
Conclusions
Our results establish a novel molecular basis for increased chemotransduction that contributes to excessive sympathetic activity before the onset of hypertension.
Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension; Feng et al 76
Abstract Rationale
Angiotensin converting enzyme type 2 (ACE2) is a new member of the brain renin-angiotensin system, that might be activated by an overactive renin-angiotensin system.
Objective
To clarify the role of central ACE2 using a new transgenic mouse model with human (h)ACE2 under the control of a synapsin promoter, allowing neuron-targeted expression in the central nervous system.
Methods and Results
Syn-hACE2 (SA) transgenic mice exhibit high hACE2 protein expression and activity throughout the brain. Baseline hemodynamic parameters (telemetry), autonomic function, and spontaneous baroreflex sensitivity (SBRS) were not significantly different between SA mice and nontransgenic littermates. Brain-targeted ACE2 overexpression attenuated the development of neurogenic hypertension (Ang II infusion: 600 ng/kg per minute for 14 days) and the associated reduction of both SBRS and parasympathetic tone. This prevention of hypertension by ACE2 overexpression was reversed by blockade of the Ang-(1-7) receptor (d-Ala7-Ang- [1] [2] [3] [4] [5] [6] [7] ; 600 ng/ kg per minute). Brain angiotensin II type 2 (AT2)/AT1 and Mas/AT1 receptor ratios were significantly increased in SA mice. They remained higher following Ang II infusion but were dramatically reduced after Ang-(1-7) receptor blockade. ACE2 overexpression resulted in increased NOS and NO levels in the brain, and prevented the Ang II-mediated decrease in NOS expression in regions modulating blood pressure regulation.
Conclusions
ACE2 overexpression attenuates the development of neurogenic hypertension partially by preventing the decrease in both SBRS and parasympathetic tone. These protective effects might be mediated by enhanced NO release in the brain resulting from Mas and AT2 receptor upregulation. Taken together, our data highlight the compensatory role of central ACE2 and its potential benefits as a therapeutic target for neurogenic hypertension.
Cyclooxygenase-2-Dependent Prostacyclin Formation and Blood Pressure Homeostasis: Targeted Exchange of Cyclooxygenase Isoforms in Mice; Yu et al 77
Abstract Rationale
Cyclooxygenase (COX)-derived prostanoids (PGs) are involved in blood pressure homeostasis. Both traditional nonsteroidal antiinflammatory drugs (NSAIDs) that inhibit COX-1 and COX-2 and NSAIDs designed to be selective for inhibition of COX-2 cause sodium retention and elevate blood pressure.
Objective
To elucidate the role of COX-2 in blood pressure homeostasis using COX-1>COX-2 mice, in which the COX-1 expression is controlled by COX-2 regulatory elements.
Methods and Results
COX-1>COX-2 mice developed systolic hypertension relative to wild types (WTs) on a high-salt diet (HSD); this was attenuated by a PGI2 receptor agonist. HSD increased expression of COX-2 in WT mice and of COX-1 in COX-1>COX-2 mice in the inner renal medulla. The HSD augmented in all strains urinary prostanoid metabolite excretion, with the exception of the major PGI2 metabolite that was suppressed on regular chow and unaltered by the HSD in both mutants. Furthermore, inner renal medullary expression of the receptor for PGI2, but not for other prostanoids, was depressed by HSD in WT and even more so in both mutant strains. Increasing osmolarity augmented expression of COX-2 in WT renal medullary interstitial cells and again the increase in formation of PGI2 observed in WTs was suppressed in cells derived from both mutants. Intramedullary infusion of the PGI2 receptor agonist increased urine volume and sodium excretion in mice.
Conclusions
These studies suggest that dysregulated expression of the COX-2 dependent, PGI2 biosynthesis/response pathway in
Functional Recapitulation of Smooth Muscle Cells Via Induced Pluripotent Stem Cells From Human Aortic Smooth Muscle Cells; Lee et al 79
Abstract Rationale
Generation of induced pluripotent stem (iPS) cells has been intensively studied by a variety of reprogramming methods, but the molecular and functional properties of the cells differentiated from iPS cells have not been well characterized.
Objective
To address this issue, we generated iPS cells from human aortic vascular smooth muscle cells (HASMCs) using lentiviral transduction of defined transcription factors and differentiated these iPS cells back into smooth muscle cells (SMCs).
Methods and Results
Established iPS cells were shown to possess properties equivalent to human embryonic stem cells, in terms of the cell surface markers, global mRNA and microRNA expression patterns, epigenetic status of OCT4, REX1, and NANOG promoters, and in vitro/in vivo pluripotency. The cells were differentiated into SMCs to enable a direct, comparative analysis with HASMCs, from which the iPS cells originated. We observed that iPS cell-derived SMCs were very similar to parental HASMCs in gene expression patterns, epigenetic modifications of pluripotency-related genes, and in vitro functional properties. However, the iPS cells still expressed a significant amount of lentiviral transgenes (OCT4 and LIN28) because of partial gene silencing.
Conclusions
Our study reports, for the first time, the generation of iPS cells from HASMCs and their differentiation into SMCs. Moreover, a parallel comparative analysis of human iPS cell-derived SMCs and parental HASMCs revealed that iPS-derived cells possessed representative molecular and in vitro functional characteristics of parental HASMCs, suggesting that iPS cells hold great promise as an autologous cell source for patientspecific cell therapy.
